Document is current

Any future updates will be listed below

Correction to: MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1)

Crossref DOI link: https://doi.org/10.1186/s13046-022-02312-6

Published Online: 2022-03-12

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark